Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
246,919,217
-
Share change
-
-6,854,879
-
Total reported value
-
$9,947,792,896
-
Put/Call ratio
-
58%
-
Price per share
-
$40.31
-
Number of holders
-
773
-
Value change
-
-$271,064,081
-
Number of buys
-
277
-
Number of sells
-
350
Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2018
As of 30 Jun 2018 GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) had 773 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 246,919,217 shares of stock of the company.
Largest 10 holders included DODGE & COX, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and Black Creek Investment Management Inc..
This table shows 776 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.